- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00657085
Evaluation of the LightSheer HS Hand Piece as Compared to the LightSheer ET Hand Piece for the Intended Use of Hair Removal and Permanent Hair Reduction
December 10, 2008 updated by: Lumenis Be Ltd.
To observe the qualitative comparison of follicular damage between treatment with the LightSheer Duet hand pieces (ET and HS) as assessed by horizontal biopsy.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Anticipated)
5
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States
- Seaver Soon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
5 Adult male subjects that have sought laser back hair removal
Description
Inclusion Criteria:
- Healthy male adult, 18 years of age or older with skin type I-V;
- Having a suitable treatment area for hair removal with brown or black hair (no gray);
- Able and willing to comply with the treatment/follow-up schedule and requirements;
- Able to read, understand and provide written Informed Consent.
Exclusion Criteria:
- Showing symptoms of hormonal disorders, as per the Investigator's discretion;
- Use of oral isotretinoin (Accutane®) within 6 months, or off label use of topical isotretinoin in immediate treated area or in its proximity within 3 months, of study enrollment or during the course of the study;
- Prior skin treatment with laser or other devices on the same treated areas prior to study enrollment or during the course of the study;
- Adverse reaction to the treatment gel to be used in the evaluation;
- History of keloid formation or poor wound healing in a previously injured skin area;
- Significant skin conditions affecting treated area or inflammatory skin conditions;
- Open laceration, abrasion, active cold sores or herpes sores on area to be treated;
- History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or use of immunosuppressive medications;
- Having a bleeding disorder or taking anticoagulation medications within the preceding 6 months;
- Having or undergoing any form of treatment for active cancer, or having a history of skin cancer or any other cancer in the area to be treated;
- Significant concurrent illness, such as diabetes, lupus, epilepsy or cardiac disorders, which might be aggravated as a result of treatment;
- Unable or unlikely to refrain from tanning, including the use of tanning booths, tanning spray or cream, during the course of the evaluation;
- Photosensitivity disorder that can be exacerbated by infrared light;
- Tattoos in the treatment areas;
- Dysplastic nevi in the treatment areas;
- Allergy or history of an allergy to the topical anesthetic used.
- Participation in a study of another device or drug within 3 months prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria;
- Mentally incompetent, prisoner or evidence of active substance or alcohol abuse;
- Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Follicular damage assessed by histology
Time Frame: first visit
|
first visit
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Comparison of permanent hair reduction between ET and HS handpieces
Time Frame: 2 month follow up visit
|
2 month follow up visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Seaver Soon, MD, Scripps Dermatology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
December 1, 2008
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
April 8, 2008
First Submitted That Met QC Criteria
April 11, 2008
First Posted (Estimate)
April 14, 2008
Study Record Updates
Last Update Posted (Estimate)
December 12, 2008
Last Update Submitted That Met QC Criteria
December 10, 2008
Last Verified
December 1, 2008
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LUM-ABU-HSET-0607-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laser Hair Removal
-
University of MichiganCompletedLaser Hair Removal in Healthy SubjectsUnited States
-
Alexandria UniversityRecruitingChanges in Bacterial Count in Axilla After Laser Hair RemovalEgypt
-
Cutera Inc.WithdrawnLaser Tattoo RemovalCanada
-
Philips HealthcareCompleted
-
Lumenis Be Ltd.CompletedHair RemovalUnited States
-
Syneron MedicalCompletedHair RemovalUnited States
-
University of Nove de JulhoNot yet recruiting
-
Syneron MedicalCompleted